H-LYDRLASTV-OH

Rif. 3D-PP43594

Informazioni sul prodotto

• Nome: H-LYDRLASTV-OH
• Sinonimi: NH2-Leu-Tyr-Asp-Arg-Leu-Ala-Ser-Thr-Val-OH

Descrizione

Peptide H-LYDRLASTV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-LYDRLASTV-OH include the following: In silico analyses and experimental validation of the MHC class-I restricted epitopes of Ebolavirus GP Y Liu, B Sun, J Wang, H Sun, Z Lu, L Chen - International , 2022 - academic.oup.comhttps://academic.oup.com/intimm/article-abstract/34/6/313/6534472 B and T cell epitope-based peptides predicted from evolutionarily conserved and whole protein sequences of Ebola virus as vaccine targets T Yasmin , AHMN Nabi - Scandinavian journal of immunology, 2016 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/sji.12425 Prediction and identification of mouse cytotoxic T lymphocyte epitopes in Ebola virus glycoproteins S Wu, T Yu, X Song, S Yi, L Hou, W Chen - Virology Journal, 2012 - Springerhttps://link.springer.com/article/10.1186/1743-422X-9-111 Alphavirus replicon DNA vectors expressing Ebola GP and VP40 antigens induce humoral and cellular immune responses in mice S Ren, Q Wei, L Cai, X Yang, C Xing, F Tan - Frontiers in , 2018 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fmicb.2017.02662/full Immunological perspective for Ebola virus infection and various treatment measures taken to fight the disease S Jain , SF Khaiboullina, M Baranwal - Pathogens, 2020 - mdpi.comhttps://www.mdpi.com/2076-0817/9/10/850 DNA-launched RNA replicon vaccines induce potent anti-Ebolavirus immune responses that can be further improved by a recombinant MVA boost P aca–hlund, J Garcaca­a-Arriaza , E Zusinaite, I Szurgot - Scientific reports, 2018 - nature.comhttps://www.nature.com/articles/s41598-018-31003-6 Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice K Konduru, SB Bradfute , J Jacques - Vaccine, 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X1100185X Replication-Deficient Ebolavirus as H Feldmann, Y Kawaoka , SW Hatta, M Suresh - J. Virol, 2009 - Citeseerhttps://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=6567e9c22434875a5a45637303d0b3dffeb67c83 In silico prediction of Ebola Zaire GP1,2 immuno-dominant epitopes for the Balb/c mouse DK Dutta, K Rhodes , SC Wood - BMC immunology, 2015 - Springerhttps://link.springer.com/article/10.1186/s12865-015-0126-8 Conserved B and T cell epitopes prediction of ebola virus glycoprotein for vaccine development: an immuno-informatics approach B Ahmad , UA Ashfaq , M Rahman , MS Masoud - Microbial , 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0882401018306053

• Marchio: Biosynth